Form 8-K - Current report:
SEC Accession No. 0001279569-24-001320
Filing Date
2024-11-04
Accepted
2024-11-04 09:58:41
Documents
15
Period of Report
2024-11-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K fourfrontform8k.htm   iXBRL 8-K 29267
2 NEWS RELEASE DATED NOVEMBER 4, 2024 ex991.htm EX-99.1 8770
3 GRAPHIC logo.jpg GRAPHIC 3583
  Complete submission text file 0001279569-24-001320.txt   217703

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE ffntf-20241104.xsd EX-101.SCH 3094
5 XBRL LABEL FILE ffntf-20241104_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE ffntf-20241104_pre.xml EX-101.PRE 22372
18 EXTRACTED XBRL INSTANCE DOCUMENT fourfrontform8k_htm.xml XML 3467
Mailing Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054
Business Address 7010 E. CHAUNCEY LANE STE. 235 PHOENIX AZ 85054 (602) 633-3067
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

EIN.: 834168417 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56075 | Film No.: 241421153
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)